ЕРИТРОПОЕТИН ЯК НЕЗАЛЕЖНИЙ ПРОГНОСТИЧНИЙ ФАКТОР У ХВОРИХ НА МІЄЛОДИСПЛАСТИЧНІ СИНДРОМИ

ЕРИТРОПОЕТИН ЯК НЕЗАЛЕЖНИЙ ПРОГНОСТИЧНИЙ ФАКТОР У ХВОРИХ НА МІЄЛОДИСПЛАСТИЧНІ СИНДРОМИ

Aim: To assess the level of erythropoietin (EPO) in blood sera of patients with different subtypes of myelodysplastic syndromes (MDS) from different risk subgroups and to determine its prognostic role. Materials and Methods: EPO was measured by enzyme-linked immunosorbent assay in peripheral blood o...

Full description

Saved in:
Bibliographic Details
Date:2023
Main Authors: Boyko, O., Simonova, M., Knysh, N., Danysh, O., Vygovska, Y., Masliak, Z.
Format: Article
Language:English
Published: PH Akademperiodyka 2023
Subjects:
мієлодиспластичні синдроми
анемія
еритропоетин
виживаність.
Online Access:https://exp-oncology.com.ua/index.php/Exp/article/view/2021-1-11
Tags: Add Tag
No Tags, Be the first to tag this record!
Journal Title:Experimental Oncology

Institution

Experimental Oncology

Internet

https://exp-oncology.com.ua/index.php/Exp/article/view/2021-1-11

Similar Items